Associate Professor Chief, Musculoskeletal Imaging and Intervention Director, Musculoskeletal Imaging and Intervention Director, Residency Education Associate Director, Integrated Interventional Radiology Residency Program Medical Director, MSK, Stony Point Radiology

Department: Radiology

Phone: (804) 628-1989

Fax: (804) 628-1132

Email: josephina.vossen@vcuhealth.org

Address/Location:
West Hospital, East Wing

SPECIALTIES

• Musculoskeletal imaging and intervention

AREAS OF INTEREST

• Musculoskeletal imaging and intervention

EDUCATION

• M.D. - Maastricht University, School of Medicine, Maastricht, Netherlands
• Ph.D. - Utrecht University, School of Medicine, Utrecht, Netherlands
• Postdoctoral Research Fellowship - Department of Radiology, Interventional Radiology and Oncology, Johns Hopkins University School of Medicine, Baltimore, MD
• Internship, General Surgery - Department of Surgery, Lenox Hill Hospital, New York, NY
• Residency, Diagnostic Radiology – Department of Radiology, Bridgeport Hospital, Yale New Haven Health System, Bridgeport, CT
• Fellowship, Musculoskeletal Imaging and Intervention - Department of Radiology, Massachusetts General Hospital, Boston, MA

APPOINTED LEADERSHIP AND COMMITTEE POSITIONS

12/2017 – present: VCU Radiology Residency Clinical Competency Committee 

1/2017 – present: VCU Radiology Residency Curriculum Committee 

1/2013 – 6/2014: Chief Resident, Bridgeport Hospital / Yale New Haven Health Department of Radiology, Bridgeport, CT

1/2014 – 6/2014: Co-Founder Connecticut Radiologic Society Resident & Fellow Section

AWARDS AND HONORS

12/2017: Radiological Society of North America (RSNA) 2017, Cum Laude Award for Education Exhibit

7/2017: Klaus Ranniger Memorial Award for Excellence in Teaching

5/2017: 2017 Shining Knight Award, VCU Medical Center Trauma Program

12/2016: Radiological Society of North America (RSNA) 2016, Certificate of Merit Award for Education Exhibit

8/2014: Radiology Leadership Institute Leadership Summit Scholarship

4/2014: Connecticut Resident Delegate for ACR National Meeting

7/2013: Radiological Society of North America: Roentgen Research Award

4/2012: RSNA/AUR/ARRS "Introduction to Academic Radiology Program" Scholarship

12/2011: Radiological Society of North America (RSNA) 2011, Excellence in Design Award for Education Exhibit

1/2006: University of Maastricht (UM) fund, International research experience grant. Subject: Clinical management of patients with liver cancer. Trends in colorectal surgery.

1/2004: European Region Action Scheme for the Mobility of University Students (ERASMUS) fund; European Union study grant.

SCIENTIFIC ACTIVITIES

2010 – present: Reviewer Radiology

2014 – present: Reviewer Skeletal Radiology

PEER REVIEWED JOURNAL ARTICLES

• Vossen JA, Buijs M, Kamel IR. Assessment of tumor response on MR imaging after locoregional therapy. Tech Vasc Interv Radiol. 2006 Sep; 9(3):125-32. Review.
• Buijs M, Kamel IR, Vossen JA, Georgiades CS, Hong K, Geschwind JF. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging. J Vasc Interv Radiol. 2007 Aug; 18(8): 957-63.
• Liapi E, Geschwind JF, Vossen JA, Buijs M, Georgiades CS, Bluemke DA, Kamel IR. Functional MRI evaluation of tumor response in patients with neuroendocrine hepatic metastasis treated with transcatheter arterial chemoembolization. AJR Am J Roentgenol. 2008 Jan; 190(1): 67-73.
• Vossen JA, Kamel IR, Buijs M, Liapi E, Georgiades CS, Hong K, Geschwind JF. Role of functional magnetic resonance imaging in assessing metastatic leiomyosarcoma response to chemoembolization. J Comput Assist Tomogr. 2008 May-Jun; 32(3): 347-52.
• Buijs M, Vossen JA, Geschwind JF, Ishimori T, Engles JM, Acha-Ngwodo O, Wahl RL, Vali M. Specificity of the anti-glycolytic activity of 3-bromopyruvate confirmed by FDG uptake in a rat model of breast cancer. Invest New Drugs. 2008 Jun 14.
• Buijs M, Vossen JA, Hong K, Georgiades CS, Geschwind JF, Kamel IR. Chemoembolization of hepatic metastases from ocular melanoma: assessment of response with contrast-enhanced and diffusion-weighted MRI. AJR Am J Roentgenol. 2008 Jul;191(1): 285-9.
• Lee KH, Liapi E, Ventura VP, Buijs M, Vossen JA, Vali M, Geschwind JF. Evaluation of different calibrated spherical polyvinyl alcohol microspheres in transcatheter arterial chemoembolization: VX2 tumor model in rabbit liver. J Vasc Interv Radiol. 2008 Jul; 19(7):1065-9.
• Characteristic analysis of diffusion-weighted magnetic resonance imaging in differentiating hepatic hemangioma from other hypervascular liver lesions. J Comput Assist Tomogr. 2008 Sep-Oct; 32(5): 750-6.
• Vali M, Vossen JA, Buijs M, Engles JM, Liapi E, Prieto Ventura V, Khwaja A, Acha-Ngwodo O, Shanmugasundaram G, Syed L, Wahl RL, Geschwind JF. Targeting of VX2 rabbit liver tumor by selective delivery of 3-bromopyruvate: a biodistribution and survival study. J Pharmacol Exp Ther. 2008 Oct; 327(1): 32-7.
• Buijs M, Vossen JA, Frangakis C, Hong K, Georgiades CS, Chen Y, Liapi E, Geschwind JF. Nonresectable hepatocellular carcinoma: long-term toxicity in patients treated with transarterial chemoembolization – single-center experience. Radiology. 2008 Oct; 249(1): 346-54.
• Vossen JA, Buijs M, Syed L, Kutiyanwala F, Kutiyanwala M, Geschwind JF, Vali M.
• Vossen JA, Buijs M, Geschwind JF, Prieto Ventura V, Lee KH, Liapi E, Bluemke DA, Development of a new orthotopic animal model of metastatic liver cancer in the rabbit VX2 model: effect on metastases after partial hepatectomy, intra-arterial treatment with 3-bromopyruvate and chemoembolization. Clin Exp Metastasis. 2008; 25(7): 811-7.
• Lee KH, Liapi E, Vossen JA, Buijs M, Ventura VP, Georgiades CS, Hong K, Kamel I, Torbenson MS, Geschwind JF. Distribution of iron oxide-containing embosphere particles after transcatheter arterial embolization in an animal model of liver cancer: evaluation with MR imaging and implication for therapy. J Vasc Interv Radiol. 2008 Oct; 19(10): 1490-6.
• Lee KH, Liapi E, Buijs M, Vossen JA, Hong K, Georgiades CS, Geschwind JF. Consideration for implantation site of VX-2 carcinoma into rabbit liver. J Vasc Interv Radiol. 2009 Jan; 20(1): 113-7.
• Pawlik TM, Assumpcao L, Vossen JA, Buijs M, Gleisner AL, Schulick RD, Choti MA. Trends in non-therapeutic laparotomy rates in patients undergoing surgical therapy for hepatic colorectal metastases. Ann Surg Oncol. 2009 Feb; 16(2): 371-8.
• Lee KH, Liapi E, Buijs M, Vossen JA, Prieto-Ventura V, Syed LH, Geschwind JF. Percutaneous US-guided implantation of VX-2 carcinoma into rabbit liver: a comparison with open surgical method. J Surg Res. 2009 Jul; 155(1): 94-9. Kamel IR. Diffusion-weighted and Gd-EOB-DTPA-contrast-enhanced magnetic resonance imaging for characterization of tumor necrosis in an animal model. J Comput Assist Tomogr. 2009 Jul-Aug; 33(4): 626-30.
• Reyes DK, Vossen JA, Kamel IR, Azad NS, Wahlin TA, Torbenson MS, Choti MA, Geschwind JF. Single-centre phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States. Cancer J. 2009 Nov-Dec; 15(6): 526-32.
• Ganapathy-Kanniappan S, Geschwind JF, Kunjithapatham R, Buijs M, Vossen JA, Tchernyshyov I, Cole RN, Syed LH, Rao PP, Ota S, Vali M. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is pyruvylated during 3-bromopyruvate mediated cancer cell death. Anticancer Research. 2009 Dec; 29(12): 4909-18.
• Lee KH, Liapi EA, Cornell C, Reb P, Buijs M, Vossen JA, Ventura VP, Geschwind JF. Doxorubicin-loaded QuadraSphere microspheres: plasma pharmacokinetics and intratumoral drug concentration in an animal model of liver cancer. Cardiovasc Intervent Radiol. 2010 Jun; 33(3):576-82.
• Liapi E, Geschwind JF, Vali M, Khwaja AA, Prieto-Ventura V, Buijs M, Vossen JA, Ganapathy S, Wahl RL. Assessment of tumoricidal efficacy and response to treatment with 18F-FDG PET/CT after intraarterial infusion with the antiglycolytic agent 3-bromopyruvate in the VX2 model of liver tumor. J Nucl Med. 2011 Feb; 52(2): 225-30.
• Buijs M, Vossen JA, Geschwind JF, Salibi N, Pan L, Ventura VP, Liapi E, Lee KH, Kamel IR. Quantitative proton MR spectroscopy as a biomarker of tumor necrosis in the rabbit VX2 liver tumor. J Vasc Interv Radiol. 2011 Aug; 22(8): 1175-80.
• Vossen JA, Thawait SK, Golia JS, Chamarthy M, Cholewczynski W, Velasco N. Recurrent fracture of a Recovery inferior vena cava filter with pulmonary migration. Yale J Biol Med. 2012 June; 85(2): 255-259.
• Vossen JA, Albrektson J, Sensarma A, Williams SC. Clinical usefulness of adjusted D-dimer cut off values to exclude pulmonary embolism in a community hospital emergency department patient population. Acta Radiol. 2012 Sep; 53(7) : 765-8.
• Thawait SK, Vossen JA, Muro GJ, Karol I. MRI illustration of traumatic lipohemarthrosis of the wrist joint due to a scaphoid fracture. Rad Case Reports. 2012; 7(3).
• Chamarthy M, Hughes TW, Gupta M, Vossen JA, Velasco NB, Zinn K. Celiac artery stenting to facilitate hepatic Yttrium-90 radioembolization therapy. Case Rep Radiol. 2012; 2012:236732.
• Bredella M, Veld J, Vossen JA, De Amorim Bernstein K, Halpern EF, Torriani M. Adipose tissue and muscle attenuation as novel biomarkers predicting mortality in patients with extremity sarcomas. Eur Radiol. 2016 Dec;26(12):4649-4655.
• Vossen JA, Bathaii SM, Hatfield B, Hayes CW. Case report: vertebral foreign body granuloma mimicking a skeletal metastasis. Skeletal Radiol. 2018 Jun;47(6):871-875.
• Veilleux NJ, Kalore NV, Wegelin JA, Vossen JA, Jiranek WA, Wayne JS. Automated femoral version estimation without the distal femur. J Orthop Res. 2018;36(12):3161-3168.
• Riddle DL, Vossen JA, Hoover KB. Magnetic resonance imaging of patellofemoral osteoarthritis: intertester reliability and associations with knee pain and function. Clin Rheumatol. 2019 Jan 7.
• Hoover KB, Vossen JA, Hayes CW, Riddle DL. Reliability of meniscus tear description: A study using MRI from the Osteoarthritis Initiative. AJR Am J Roentgenol. (Submitted for Review)
• Hoover KB, Abbey A, Vossen JA, Haar PJ, O’Neill C, Hayes CW. Vertebral Bone Density Assessment Using Clinical CT Scans: Interaction of phase of contrast enhancement and bone mineral density measured by DXA. Skeletal Radiol. (Submitted for Review)
• Vossen JA, Abbassi M, Qian Y, Hayes CW, Haar PJ, Hoover KB. Correlation between the accessory anterolateral talar facet, bone marrow edema and tarsal coalitions. Skeletal Radiol. (Submitted for Review)

PEER REVIEWED BOOK CHAPTER

• Buijs M, Vossen JA, Geschwind JF, Kamel IR. (2008). Assessment of tumor response on MR imaging after locoregional therapy. In Soulen MC, Geschwind JF (Ed.), Interventional Oncology: Principles and Practice (pp. 86-99). New York, NY. Cambridge University Press.
• Vaughan LM, Long SA, Santamaría T, Kahn MJ, Vossen JA, Bredella MA, Schiller AL, Mankin HJ. (2016). Osteonecrosis in Patients with Sickle Cell Anemia and Other Hematologic Disorders. In Aaron RK (Ed.), Skeletal Circulation in Clinical Practice. World 
  Scientific.
• Corvec S, Portillo ME, Vossen JA. Diagnostics. In Kates SL (Ed.), Manual of Infection. AOTrauma, in cooperation with Thieme Publishers.

SCIENTIFIC ABSTRACTS AND PODIUM PRESENTATIONS

• Hong K, McBride JF, Buijs M, Vossen JA, Georgiades CS, Geschwind JF. Case control study of transarterial chemoembolization versus Yttrium90 radioembolization for palliative treatment of liver-dominant colorectal adenocarcinoma in the salvage setting. 92nd RSNA 
  Annual Meeting, Chicago, IL, 2006.
• Vossen JA, Buijs M, Kamel IR, Reyes DK, Liapi E, Hebert J, Bluemke DA, Geschwind JF. Functional MR imaging assessment of tumor response following TheraSpheres treatment in patients with unresectable hepatocellular carcinoma. 107th ARRS Annual Meeting, Chicago, 
  IL, 2007.
• Buijs M, Vossen JA, Georgiades CS, Hong K, Geschwind JF, Kamel IR. Role of functional MR imaging in assessing treatment response to transarterial chemoembolization (TACE) in patients with hepatic metastases. 107th ARRS Annual Meeting, Chicago, IL, 2007.
• Choti MA, Vossen JA, Gleisner AL, Buijs M, Assumpcao L, Schulick RD, Pawlik TM. Trends in non-therapeutic laparotomy rates in patients undergoing surgical therapy for hepatic colorectal metastases. 48th SSAT Annual Meeting, Washington, DC, 2007.
• Buijs M, Vossen JA, Georgiades CS, Hong K, Geschwind JF, Kamel IR. Role of functional MR imaging in assessing treatment response to TACE in patients with hepatic metastases. 32th SIR Annual Meeting, Seattle, WA, 2007.
• Lee KH, Liapi E, Prieto Ventura V, Buijs M, Vossen JA, Kamel IR, Geschwind JFH. Evaluation of iron oxide embospheres (IOE) particles distribution after transcatheter arterial embolization (TAE) by MR imaging in an animal model of liver Vx-2 liver tumor. 93rd RSNA Annual Meeting, Chicago, IL, 2007.
• Lee KH, Liapi E, Prieto Ventura V, Buijs M, Vossen JA, Vali M, Geschwind JFH. Evaluation of three types of microspheres with different material characteristics by transcatheter arterial chemoembolization (TACE) in the Vx-2 liver tumor rabbit. 93rd RSNA Annual Meeting, Chicago, IL, 2007.
• Vossen JA, Buijs M, Syed LH, Vali F, Kutiyanwala M, Kutiyanwala H, Lee KH, Geschwind JFH, Vali M, Liapi E. An animal model of metastatic liver cancer. 33th SIR Annual Meeting, Washington, DC, 2008.
• Lee KH, Liapi E, Vossen JA, Buijs M, Torbenson M, Hong K, Georgiades CS, Geschwind JFH. In vivo evaluation of different calibrated spherical PVA microspheres for TACE. 33th SIR Annual Meeting, Washington, DC, 2008.
• Lee KH, Liapi E, Buijs M, Vossen JA, Hong K, Georgiades CS, Geschwind JFH. Technical considerations for reliable Vx-2 liver tumor growth: selection of implantation site. 33th SIR Annual Meeting, Washington, DC, 2008.
• Lee KH, Liapi E, Buijs M, Vossen JA, Georgiades CS, Hong K, Geschwind JFH. Technical considerations for reliable Vx-2 liver tumor growth: selection of tumor cells inoculation method. 33th SIR Annual Meeting, Washington, DC, 2008.
• Lee KH, Liapi E, Buijs M, Vossen JA, Georgiades CS, Hong K, Torbenson M, Kamel IR, Geschwind JFH. Distribution of iron oxide embospheres after TAE in the Vx-2 liver tumor: evaluation with MR imaging and pathology. 33th SIR Annual Meeting, Washington, DC, 
  2008.
• Liapi E, Vali M, Buijs M, Vossen JA, Lee KH, Geschwind JFH. Survival benefits of intra-arterially administered 3-BrPA in the rabbit VX2 model of liver cancer. 33th SIR Annual Meeting, Washington, DC, 2008.
• Lee KH, Liapi E, Buijs M, Vossen JA, Georgiades CS, Hong K, Geschwind JFH. Doxorubicin loaded QuadraSphere: plasma pharmacokinetics and intratumoral drug concentration. 33th SIR Annual Meeting, Washington, DC, 2008.
• Barnett BP, Liapi E, Gilson WD, Kim K, Vossen JA, Buijs M, Vali M, Lee KH, Geschwind JF. Novel MR and CT detectable ChemoSpheres for locoregional delivery of 3-bromopyruvate and doxorubicin. 33th SIR Annual Meeting, Washington, DC, 2008.
• Buijs M, Vossen JA, Liapi E, Torbenson M, Geschwind JF and Kamel IR. Quantification of tumor necrosis using functional MR imaging with pathologic correlation in rabbits with Vx-2 tumors. 33th SIR Annual Meeting, Washington, DC, 2008.
• Vossen JA, Buijs M, Salibi N, Bluemke DA, Geschwind JF and Kamel IR. Comparison in functional MRI between targeted and non-targeted unresectable hepatic tumors treated with TACE. 33th SIR Annual Meeting, Washington, DC, 2008.
• Lee KH, Liapi E, Vossen JA, Buijs M, Hong K, Georgiades CS, Geschwind JFH. Comparison of percutaneous US-guided versus open surgery implantation technique of Vx-2 carcinoma into rabbit liver. 33th SIR Annual Meeting, Washington, DC, 2008.
• Buijs M, Vossen JA, Liapi E, Torbenson M, Geschwind JF and Kamel IR. Quantification of tumor necrosis using functional MR imaging with pathologic correlation in rabbits with Vx-2 tumors. 108th ARRS Annual Meeting, Washington, DC, 2008.
• Vossen JA, Buijs M, Salibi N, Bluemke DA, Geschwind JF and Kamel IR. Comparison in functional MRI between targeted and non-targeted unresectable hepatic tumors treated with TACE. 108th ARRS Annual Meeting, Washington, DC, 2008.
• Kamel IR, Vossen JA, Buijs M, Salibi N, Bluemke DA, and Geschwind JF. Comparison in functional and metabolic MR imaging findings between targeted and non-targeted unresectable hepatic tumors treated with TACE. 16th ISMRM Annual Meeting, Toronto, 
  Canada, 2008.
• Barnett BP, Liapi E, Geschwind JFG, Lee KH, Gilson WD, Harel Y, Vossen JA, Buijs M, Vali M. Trimodal MR, CT, and US detectable ChemoSpheres for locoregional delivery of 3-bromopyruvate and doxorubicin. 94th RSNA Annual Meeting, Chicago, IL, 2008.
• Kamel IR, Buijs M, Vossen JA, Pan L, Salibi N, Liapi E, Lorenz C, Geschwind JF. Quantitative proton MR spectroscopy as a biomarker of tumor necrosis in the rabbit VX2 liver tumor. 17th ISMRM Annual Meeting, Honolulu, Hawai, 2009.
• Ganapathy-Kanniappan S, Geschwind JF, Kunjithapatham R, Buijs M, Vossen JA, Tchernyshyov I, Torbenson MS, Cole RN, Syed LH, Vali M. A pyruvic acid analog primarily targets GAPDH to promote cancer cell death. FASEB Annual Meeting, New Orleans, LA, 
  2009.
• Vossen JA, Reyes DK, Kamel IR, Azad NS, Wahlin TA, Torbenson MS, Choti MA, Geschwind JF. Single centre phase II trial of transarterial chemoembolization with drug eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the USA. CIRSE Annual Meeting, Lisbon, Portugal, 2009.
• Reyes DK, Vossen JA, Kamel IR, Mulcahy MF, Salem R, Messersmith W, Weekes CD, Georgiades CS, Hong K, Geschwind JF. Phase II trial of bevacizumab combined with transarterial chemoembolization (TACE) for hepatocellular carcinoma: initial experience at two institutions. 3rd ILCA Annual Conference, Milan, Italy, 2009.
• Bonekamp S, Shen J, Salibi N, Lai HC, Vossen JA, Buijs M, Geschwind JF, Kamel IR. Multi-parametric MRI evaluation of tumor response in patients with hepatic malignancies treated with locoregional therapy. 95th RSNA Annual Meeting, Chicago, IL, 2009.
• Reyes DK, Vossen JA, Kamel IR, Azad NS, Wahlin TA, Torbenson MS, Choti MA, Geschwind JF. Single centre phase II trial of transarterial chemoembolization with drug eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the USA. 95th RSNA Annual Meeting, Chicago, IL, 2009.
• Ota S, Vali M, Rao PP, Syed LH, Ganapathy-Kanniappan S, Kunjithapatham R, Buijs M, Vossen JA, Kwak B, Geschwind JF. Ultrasound guided intra-tumoral injection of 3-bromopyruvate (3-BrPA) for the treatment of pancreatic cancer: Safety and efficacy in a murine orthotopic xenograft. 35th SIR Annual Meeting, Tampa, FL, 2010.
• Reyes DK, Vossen JA, Kamel IR, Azad NS, Wahlin TA, Torbenson MS, Choti MA, Geschwind JF. Single centre phase II trial of transarterial chemoembolization with drug eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the USA. 35th SIR Annual Meeting, Tampa, FL, 2010.
• Reyes DK, Vossen JA, Kamel IR, Mulcahy MF, Salem R, Messersmith W, Weekes CD, Georgiades CS, Hong K, Geschwind JF. Phase II trial of bevacizumab combined with transarterial chemoembolization (TACE) for hepatocellular carcinoma: initial experience at two institutions. 35th SIR Annual Meeting, Tampa, FL, 2010.
• Chamarthy M, Thawait S, Vossen JA, Kolnick D, Banker P, Zampolin R, Stein S. Revisiting the Diagnostic Clues to Localize the Subtle and Occult Fractures on Plain Radiography. 111th ARRS Annual Meeting, Chicago, IL, 2011.
• Chamarthy M, Gupta M, Thawait SK, Vossen JA, Moadel R. Selective Internal Radiation therapy 101: the basics. 25th Annual Bridgeport Hospital Science Symposium, Bridgeport, CT, 2011.
• Vossen JA. Intra-arterial treatment and follow-up of primary and metastatic liver tumors. 25th Annual Bridgeport Hospital Science Symposium, Bridgeport, CT, 2011.
• Vossen JA, Albrektson J, Sensarma A, Rosovsky MA. Screening for renal disease using eGFR: who are we hurting? ACR Quality and Safety Conference, Scottsdale, AZ, 2012.
• Vossen JA, Albrektson J, Sensarma A, Williams SC. Clinical usefulness of adjusted D-dimer cut off values to exclude pulmonary embolism in an emergency department patient population. 26th Annual Bridgeport Hospital Science Symposium, Bridgeport, CT, 2012.
• Abbassi M, Vossen JA, Haar PJ, Hayes CW, Hoover KB. Accessory anterolateral talar facet: Correlating MRI findings in an anatomic variant. ARRS Annual Meeting, New Orleans, LA, 2017.
• Abbassi M, Vossen JA, Haar PJ, Hoover KB. Tarsal coalition and the accessory anterolateral facet. 104th RSNA Annual Meeting, Chicago, IL, 2018.

POSTERS AMD EDUCATIONAL EXHIBITS

• McBride JF, Hong K, Buijs M, Vossen JA, Georgiades CS, Geschwind JF. Transarterial chemoembolization of liver-dominant neuroendocrine tumors: technical feasibility, safety, and efficacy. 92nd RSNA Annual Meeting, Chicago, IL, 2006.
• Kamel IR, Buijs M, Vossen JA, Georgiades CS, Hong K, Geschwind JF. Role of functional MR imaging is assessing treatment response to transarterial chemoembolization (TACE) in patients with hepatic metastases. 15th ISMRM Annual Meeting, Berlin, Germany, 2007. 
• Hong K, Buijs M, Vossen JA, Georgiades CS, Geschwind JF. Standardized reporting of toxicity and outcome of transcatheter arterial chemoembolization for unresectable HCC. 33th SIR Annual Meeting, Washington, DC, 2008. 
• Liapi E, Vali M, Buijs M, Vossen JA, Lee KH, Geschwind JFH. Survival benefit and tumor response of intra-arterially administered 3-BrPA in the rabbit VX2 model of liver cancer. 2nd ILCA Annual Conference, Chicago, IL, 2008. 
• Reyes DK, Vossen JA, Kamel IR, Mulcahy M, Salem R, Messersmith W, Weekes C, Georgiades CS, Hong K, Geschwind JF. Phase II trial of bevacizumab combined with transarterial chemoembolization (TACE) for hepatocellular carcinoma: initial experience at two institutions. CIRSE Annual Meeting, Lisbon, Portugal, 2009. 
• Vossen JA, Reyes DK, Kamel IR, Azad NS, Wahlin TA, Torbenson MS, Choti MA, Geschwind JF. Single centre phase II trial of transarterial chemoembolization with drug eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the USA. ILCA 3rd Annual Conference, Milan, Italy, 2009. 
• Reyes DK, Vossen JA, Kamel IR, Mulcahy M, Salem R, Messersmith W, Weekes C, Georgiades CS, Hong K, Geschwind JF. Phase II trial of bevacizumab combined with transarterial chemoembolization (TACE) for hepatocellular carcinoma: initial experience at 
  two institutions. 46th ASCO Annual Meeting, Chicago, IL, 2010. 
• Vossen JA, Thawait SK, Chamarthy M, Velasco N. Recurrent fracture of a Recovery inferior vena cava filter with pulmonary migration. 25th Annual Bridgeport Hospital Science Symposium, Bridgeport, CT, 2011. 
• Thawait SK, Vossen JA, Chamarthy M, Karol I. Traumatic Lipohemarthrosis of the wrist joint due to a scaphoid fracture. 25th Annual Bridgeport Hospital Science Symposium, Bridgeport, CT, 2011. 
• Vossen JA, Edwards SD, Reeser PM, Pronovost M. Accuracy and upgrade rates of stereotactic vacuum-assisted breast biopsy: Impact of number of core samples taken on malignancy underestimation rates. 2011 ASCO Breast Cancer Symposium, San Francisco, CA, 2011. 
• Edwards SD, Vossen JA, Reeser PM, Pronovost M Accuracy of stereotactic vacuum-assisted biopsies in a community population. 2011 ASCO Breast Cancer Symposium, San Francisco, CA, 2011. 
• Chamarthy M, Miller TS, Thawait SK, Vossen JA, Muro GJ, Brook AL. Diagnostic and therapeutic spinal angiogram: normal anatomy, common variants, and pathologies. 97th RSNA Annual Meeting, Chicago, IL, 2011. 
• Vossen JA, Thawait SK, Chamarthy M, McIntyre JJ, Rosovsky MA, Muro GJ, Meszaros MD. Vertebroplasty: imaging spectrum; preprocedural imaging, expected postprocedural changes and complications. 97th RSNA Annual Meeting, Chicago, IL, 2011. 
• Thawait SK, Batra K, Thawait GK, Vossen JA, Chamarthy M, Chhabra A. Systematic approach to MR evaluation of non ovarian adnexal lesions. 34th SCBT-MR Annual Meeting, Washington, DC, 2011. 
• Thawait SK, Batra K, Thawait GK, Vossen JA, Dhangana R, Chhabra A. Magnetic resonance imaging of non ovarian adnexal lesions. ECR Annual Meeting, Vienna, Austria, 2012. 
• Vossen JA, Golia JS, Thawait SK, Chamarthy M, Meszaros MD. Vertebroplasty: imaging spectrum; preprocedural imaging, postprocedural imaging and complications. 26th Annual Bridgeport Hospital Science Symposium, Bridgeport, CT, 2012. 
• Golia JS, Vossen JA, Chamarthy M, Thawait SK, Lam C, Karol I. The many faces of superior mesenteric artery aneurysms. 26th Annual Bridgeport Hospital Science Symposium, Bridgeport, CT, 2012. 
• Vossen JA, Golia JS, Chamarthy M, Thawait SK, Hughes T, Zinn K. Celiac axis stenting prior to radioembolization in the setting of celiac occlusion. CIRSE Annual Meeting, Lisbon, Portugal, 2012. 
• Golia JS, Vossen JA, Chamarthy M, Thawait SK, Lam C, Karol I. The many faces of superior mesenteric artery aneurysms. 98th RSNA Annual Meeting, Chicago, IL, 2012. 
• Vossen JA, Golia JS, Thawait SK, Chamarthy M, Marrinan GB. “Youth is wasted on the young?” MRI of the adolescent athlete. 98th RSNA Annual Meeting, Chicago, IL, 2012. 
• Golia JS, Vossen JA, Thawait SK, Chamarthy M, Goodstine SL. Quality control in mammography: A picture gallery. 98th RSNA Annual Meeting, Chicago, IL, 2012. 
• Vossen JA, Golia JS, Thawait SK, Chamarthy M, Marrinan GB. Invincible Youth?; Lower extremity MRI of the adolescent athlete. 35th SCBT-MR Annual Meeting, Boston, MA, 2012. 
• Thawait SK, Vossen JA, Chamarthy M, Golia JS, Chhabra A, Zaheer A. Infectious diseases of the liver: CT and MR imaging patterns. 35th SCBT-MR Annual Meeting, Boston, MA, 2012.
• Miller L, Vossen JA, Marrinan GB. Benign cystic lesions of the ovary: Diagnosis with MR imaging. 21th ISMRM Annual Meeting, Salt Lake City, UT. 
• Miller L, Lu F, Vossen JA, Marrinan GB. Imaging of PE in pregnancy: Choice of CT angiography or nuclear medicine ventilation/perfusion scan. 99th RSNA Annual Meeting, Chicago, IL, 2013. 
• Fedele D, Miller L, Lu F, Vossen JA, Marrinan GB. Imaging of primary carcinoma of the fallopian tube. ECR Annual Meeting, Vienna, Austria, 2014. 
• Miller L, Fedele D, Lu F, Vossen JA, Karol I. Imaging of non-obstetric pelvic pain in the pregnant patient. ECR Annual Meeting, Vienna, Austria, 2014. 
• Vossen JA, Golia JS, Miller L, Fedele D, Velasco N. Pictorial review of IVC filters and their complications. ECR Annual Meeting, Vienna, Austria, 2014. 
• Fedele DL, Vossen JA, Meszaros MD. CT and MRI ordering algorithm for non-radiology residents. AUR 62nd Annual Meeting, Baltimore, MD, 2014. 
• Miller L, Vossen JA, Fedele D, Golia JS, Thawait S, Marrinan GB. Imaging of winter sports related injuries of the upper extremity. 37th SCBT-MR Annual Meeting, New Orleans, LA, 2014. 
• Vossen JA, Golia JS, Miller L, Marrinan GB, Torriani M. Imaging review of the accessory ossicles of the foot. 100th RSNA Annual Meeting, Chicago, IL, 2014. 
• Vossen JA, Myrick P, Haar PJ, Hoover KB, Hayes CW. Pelvic trauma: What every radiologist should know. 102th RSNA Annual Meeting, Chicago, IL, 2016. 
• Chadwick N, Hoover KB, Hayes CW, Haar PJ, Vossen JA, Miller K. Design and impact of a MSK image-guided procedure curriculum for radiology residents. AUR Annual Meeting. Hollywood, FL, 2017. 
• Berl SD, Vossen JA, Haar PJ, Hoover KB, Hayes CW. Imaging of hip dysplasia and periacetabular osteotomy: What the orthopedist wants to know. ARRS Annual Meeting, New Orleans, LA, 2017. 
• Myrick P, Vossen JA, Haar PJ, Hoover KB, Hayes CW. Palpable hand and wrist masses. ARRS Annual Meeting, New Orleans, LA, 2017. 
• Vossen JA, Patel T, Haar PJ, Hoover KB, Hayes CW. Non-traumatic foot radiographs: What the foot specialist wants to know. ARRS Annual Meeting, New Orleans, LA, 2017. 
• Vossen JA, Petty CH, Haar PJ, Hayes CW, Hoover KB. The antibiotic spacer: What every radiologist should know. 103rd RSNA Annual Meeting, Chicago, IL, 2017. Presented during CME Lunch Hour Discussion Session. 
• Vossen JA, Herczyk MD, Loken EK, Haar PJ, Hayes CW, Hoover KB. Talar trauma: What the orthopedist wants to know. 103rd RSNA Annual Meeting, Chicago, IL, 2017. 
• Vossen JA, Haar PJ, Hayes CW, Hoover KB. Post-traumatic heterotopic ossification: A pictorial review. 103rd RSNA Annual Meeting, Chicago, IL, 2017. 
• Vossen JA, Haar PJ, Hayes CW, Perone M, Hoover KB. MRI interpretation rather than tissue diagnosis determines acute osteomyelitis management: one institution’s experience. SSR Annual Meeting, Austin, TX, 2018. 
• Vossen JA, Kim C, Haar PJ, Hayes CW, Hoover KB. Periosteal reaction as the only visualized sign of osteonecrosis on radiographs. SSR Annual Meeting, Austin, TX, 2018. 
• Veilleux NJ, Kalore NV, Wegelin JA, Vossen JA, Haar PJ, Jiranek WA, Wayne JS. Automated femoral version estimation without the distal femur. ORS Annual Meeting, New Orleans, LA, 2018. 
• Haar PJ, Groves RC, Vossen JA, Hayes CW, Hoover KB, Fulcher AS. Positive benefits of radiology residents as teaching assistants in a medical school radiology curriculum involving postmortem CT scanning of cadavers. AUR Annual Meeting. Orlando, FL, 2018. 
• Haar PJ, Vossen JA, Hayes CW, Hoover KB, Groves RC, Fulcher AS. Increased medical student interest in radiology following a curriculum involving postmortem CT scanning of gross anatomy cadavers. AUR Annual Meeting. Orlando, FL, 2018. 
• Gola S, Haar PJ, Hoover KB, Vossen JA. Design and Impact of a Musculoskeletal (MSK) Image-Guided Procedure Curriculum for Radiology Residents. 104th RSNA Annual Meeting, Chicago, IL, 2018.
• Vossen JA, Goodman WC, Haar PJ, Hoover KB. Calcaneal Trauma: What the Orthopedist Wants to Know. 104th RSNA Annual Meeting, Chicago, IL, 2018.
• Vossen JA, Ahn L, Haar PJ, Hoover KB. Temporomandibular Joint: An Imaging Primer. 104th RSNA Annual Meeting, Chicago, IL, 2018.

OTHER INSTRUCTIONAL MATERIAL

• Vossen JA, Marrinan G: ACR Case in Point: Adventitious bursitis. 1/19/2015.
• Gola S, Vossen JA: ACR Case in Point: Quadrilateral space syndrome. Accepted.
• Kang S, Vossen JA: ACR Case in Point: Glenolabral articular disruption lesion (GLAD). 11/5/2018
• Ovanez C, Vossen JA: ACR Case in Point: Spinoglenoid notch cyst. Accepted.

INVITED LECTURES

• Imaging of back pain - Workshop. Presented at the Best Practices in Pain Management Meeting. Williamsburg, VA, 2017
• Musculoskeletal ultrasound. Orthopedic Grand Rounds. Richmond, VA, 2018
• Radiology for Emergency residents in Mozambique, presented via Zoom, 2018
• Diagnostic radiology studies in sports medicine. Presented at the Sports Medicine Essentials Meeting. Richmond, VA, 2018
• Radiology for VCU Physical Therapy Students. Richmond, VA, 2018, 2019

INVENTIONS AND PATENTS

A New Formulation of 3-Bromopyruvate for Safe Systemic Administration as an Anti-Cancer Agent; Report of Invention (JHU Ref#: C10445): 2008. Inventors : Geschwind JF, Vali M, Buijs M, Vossen JA

BOARD CERTIFICATION

• American Board of Radiology

Back to Listing